Canopy Growth Corp Files Proxy Statement Supplement

Ticker: CGC · Form: DEFA14A · Filed: 2024-09-13T00:00:00.000Z

Sentiment: neutral

Topics: proxy-statement, sec-filing, corporate-governance

TL;DR

Canopy Growth filed a proxy update, no fee. Standard procedure.

AI Summary

Canopy Growth Corporation filed a DEFA14A on September 13, 2024, to supplement its definitive proxy statement. The filing is related to the company's proxy materials and does not appear to involve a fee, as indicated by the 'No fee required' checkbox. The company's principal executive offices are located in Smith Falls, Ontario, Canada.

Why It Matters

This filing is a routine update to Canopy Growth's proxy materials, providing shareholders with necessary information for upcoming corporate decisions or meetings.

Risk Assessment

Risk Level: low — This is a routine administrative filing related to proxy statements, not indicating any immediate financial or operational risks.

Key Players & Entities

FAQ

What is the purpose of this DEFA14A filing?

This DEFA14A filing serves as a supplement to Canopy Growth Corporation's definitive proxy statement, providing updated or additional information to shareholders.

When was this filing submitted to the SEC?

This filing was submitted on September 13, 2024.

Was there a fee associated with this filing?

No, the filing indicates that no fee was required for this submission.

Where are Canopy Growth Corporation's principal executive offices located?

Canopy Growth Corporation's principal executive offices are located at 1 Hershey Drive, Smith Falls, Ontario, K7A0A8.

What is the standard industrial classification for Canopy Growth Corporation?

The standard industrial classification for Canopy Growth Corporation is MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].

From the Filing

0001104659-24-099549.txt : 20240913 0001104659-24-099549.hdr.sgml : 20240913 20240913083007 ACCESSION NUMBER: 0001104659-24-099549 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240913 DATE AS OF CHANGE: 20240913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Canopy Growth Corp CENTRAL INDEX KEY: 0001737927 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38496 FILM NUMBER: 241296504 BUSINESS ADDRESS: STREET 1: 1 HERSHEY DRIVE CITY: SMITH FALLS STATE: A6 ZIP: K7A0A8 BUSINESS PHONE: 855-558-9333 MAIL ADDRESS: STREET 1: 1 HERSHEY DRIVE CITY: SMITH FALLS STATE: A6 ZIP: K7A0A8 DEFA14A 1 tm2423993d1_defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material under §240.14a-12 CANOPY GROWTH CORPORATION (Name of Registrant as Specified in Its Charter) N/A (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): x No fee required ¨ Fee paid previously with preliminary materials. ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. This proxy statement supplement (this “Supplement”), dated September 13, 2024, supplements and amends the definitive proxy statement (the “Proxy Statement”) filed by Canopy Growth Corporation (the “Company,” “we,” or “our”) with the U.S. Securities and Exchange Commission (the “SEC”) and Canadian securities regulators on August 1, 2024 relating to our 2024 Annual General Meeting of holders (the “Shareholders”) of common shares of the Company to be held on September 24, 2024 (the “Meeting”). This Supplement should be read together with the Proxy Statement. Other than as set forth below, no changes have been made to the Proxy Statement. Engagement of Additional Proxy Solicitor As previously disclosed in the Proxy Statement under the heading “About the Meeting—Solicitation of Proxies,” we previously engaged Laurel Hill Advisory Group LLC (“Laurel Hill”), a professional proxy solicitation firm, to aid in the solicitation of proxies from our Shareholders in connection with the Meeting. Subsequent to filing the Proxy Statement, we also engaged Alliance Advisors, LLC (“Alliance Advisors”), a professional proxy solicitation firm, to assist in soliciting proxies from our Shareholders on our behalf in connection with the Meeting. We have agreed to pay Alliance Advisors up to US$100,000 in fees, which includes costs and expenses. We will bear all proxy solicitation costs. If Shareholders need assistance with casting or changing their vote on a particular issue to be decided at the Meeting, they should contact one of our proxy solicitors listed below. Shareholders who have already voted and do not wish to change their vote do not need to take any further action. Laurel Hill Email: assistance@laurelhill.com North American Toll Free Phone: 1-877-452-7184 Outside North America: 416-304-0211 Alliance Advisors Email: cgc@allianceadvisors.com North American Toll Free Phone: 855-643-7453 Outside North America: 1-551-210-9931 Important Information We have filed the Proxy Statement with th

View on Read The Filing